Literature DB >> 19107103

Can nutritional therapy replace pharmacologic therapy in pediatric Crohn's disease?

Miquel A Gassull1.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 19107103     DOI: 10.1038/ncpgasthep1338

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN: 1743-4378


× No keyword cloud information.
  14 in total

1.  Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial.

Authors:  Osvaldo Borrelli; Letizia Cordischi; Manuela Cirulli; Massimiliano Paganelli; Valeria Labalestra; Stefania Uccini; Paolo M Russo; Salvatore Cucchiara
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05-06       Impact factor: 11.382

Review 2.  Enteral nutritional therapy for induction of remission in Crohn's disease.

Authors:  M Zachos; M Tondeur; A M Griffiths
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 3.  Enteral nutrition for maintenance of remission in Crohn's disease.

Authors:  A K Akobeng; A G Thomas
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 4.  Macronutrients and bioactive molecules: is there a specific role in the management of inflammatory bowel disease?

Authors:  Miquel A Gassull; Josep Mañé; Elisabet Pedrosa; Eduard Cabre
Journal:  JPEN J Parenter Enteral Nutr       Date:  2005 Jul-Aug       Impact factor: 4.016

Review 5.  Meta-analysis: enteral nutrition in active Crohn's disease in children.

Authors:  P Dziechciarz; A Horvath; R Shamir; H Szajewska
Journal:  Aliment Pharmacol Ther       Date:  2007-09-15       Impact factor: 8.171

6.  How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials.

Authors:  F Fernández-Banares; E Cabré; M Esteve-Comas; M A Gassull
Journal:  JPEN J Parenter Enteral Nutr       Date:  1995 Sep-Oct       Impact factor: 4.016

7.  Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial.

Authors:  M A Gassull; F Fernández-Bañares; E Cabré; M Papo; M H Giaffer; J L Sánchez-Lombraña; C Richart; H Malchow; F González-Huix; M Esteve
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

8.  A comparison of budesonide with prednisolone for active Crohn's disease.

Authors:  P Rutgeerts; R Löfberg; H Malchow; C Lamers; G Olaison; D Jewell; A Danielsson; H Goebell; O O Thomsen; H Lorenz-Meyer
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245

9.  Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group.

Authors:  S Bar-Meir; Y Chowers; A Lavy; D Abramovitch; A Sternberg; G Leichtmann; R Reshef; S Odes; M Moshkovitz; R Bruck; R Eliakim; E Maoz; U Mittmann
Journal:  Gastroenterology       Date:  1998-10       Impact factor: 22.682

Review 10.  IBD in children: lessons for adults.

Authors:  Cindy A Haller; James Markowitz
Journal:  Curr Gastroenterol Rep       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.